| Name | Market | Market CAP | Share price | Daily share movement |
|---|---|---|---|---|
| Advanced Medical Solutions Group | AIM | £501.73 m | 232.85 GBX | 0.58% |
| Advanced Micro Devices, Inc. | NASDAQ | $99.73 billion | 82.42 USD | -5.20% |
| Advanced Nano Technologies Ltd | ASX | $239.95 m | 4.00 AUD | -1.48% |
| Advanced Oncotherapy PLC | LSE | £139.62 m | 40.00 GBX | -2.44% |
| Advanced Oxygen Technologies, Inc. | PINK | $691.52 k | 0.21 USD | 10.53% |
| Advanced Photonix, Inc. | NYSE | $6.24 billion | 62.89 USD | -10.08% |
| Advanced Proteome Therapeutics Corp. | TSX-V | $7.54 m | 0.27 CAD | 5.88% |
| Advanced Share Registry Limited | ASX | $37.82 m | 0.88 AUD | -1.68% |
| Advanced Vision Technology | FRA | 0.00 | 0.00% | |
| Advanced Voice Recognition Systems, Inc. | PINK | $5.6 m | 0.02 USD | -6.98% |
| AdvanSource Biomaterials Corp. | OTCQB | $847.87 k | 0.03 USD | -37.37% |
| Advant-e Corp. | PINK | $31.63 m | 5.30 USD | 5.79% |
| Advantage Lithium Corp. | TSX-V | $43.14 m | 0.27 CAD | -3.64% |
| Advantage Oil & Gas Ltd. | TSX | $489.09 m | 2.60 CAD | -4.76% |
| Advantaged CDN High Yield Bond Fund | TSX | $15.92 m | 7.31 CAD | -0.27% |
| Advantest | NYSE | 0.00 | 0.00% | |
| Advaxis | NASDAQ | $98.28 m | 0.88 USD | -12.57% |
| Advent Software, Inc. | NASDAQ | 0.00 | 0.00% | |
| Adventure Gold Inc | TSX-V | $0.00 | 0.00 CAD | 0.00% |
| ADVENTUS ZINC CORPORATION | TSX-V | $115.36 m | 0.88 CAD | -4.35% |
| Adveritas Ltd | ASX | $64.25 m | 0.18 AUD | 0.00% |
| Adverum Biotechnlogies Inc | NASDAQ | $1.22 billion | 12.52 USD | -5.79% |
| ADVFN | AIM | £7.98 m | 31.05 GBX | -7.31% |
| AdvisorShares ETF | NYSEMKT | $441.12 m | 25.91 USD | -5.20% |
| ADX Energy Limited | ASX | $22.19 m | 0.01 AUD | -10.00% |
| AECOM Technology | NYSE | $8.72 billion | 59.04 USD | -1.40% |
| Aecon Group | TSX | $1.04 billion | 17.36 CAD | 1.82% |
| Aeeris Ltd | ASX | $6.3 m | 0.11 AUD | -12.50% |
| AEGEAN Airlines | PINK | $368.51 m | 5.16 USD | -13.57% |
| Aegle Therapeutics Corp | Unlisted | 0.00 | 0.00% | |
| Aeglea Biotherapeutics | NASDAQ | $354.26 m | 7.39 USD | 1.65% |
| Aehr Test Systems | NASDAQ | $68.13 m | 2.90 USD | -9.38% |
| Aemetis Inc | NASDAQ | $195.91 m | 9.90 USD | 2.80% |
| Aeolus Pharmaceuticals, Inc. | PINK | $1.83 m | 0.01 USD | 9.09% |
| AEON Biopharma | Unlisted | 0.00 | 0.00% | |
| Aeon Metals Ltd | ASX | $81.31 m | 0.12 AUD | 0.00% |
| Aeorema Communications | AIM | £2.59 m | 28.00 GBX | 0.00% |
| AEP Industries | NASDAQ | 0.00 | 0.00% | |
| Aequus Pharmaceuticals Inc. | TSX-V | $22.38 m | 0.20 CAD | 0.00% |
| AER Lingus Group plc | LSE | 0.00 | 0.00% |